Rate My Professor Tracey Smith

Otago Innovation Limited, with Dr Smith instrumental in the process, received the prestigious BNZ Commercial Deal Award at the inaugural KiwiNet Research Commercialisation Awards in 2013 for the successful commercialisation of TOXINZ. This accolade highlighted the project's excellence in monetising undervalued assets and generating significant economic impact for New Zealand. Today, TOXINZ is utilised in more than 30 countries, with subscriptions purchased by over 70 hospitals and institutions worldwide, including government and ministry-level adoptions in nations such as Kazakhstan, the United Arab Emirates, and emerging markets in Asia like Malaysia and the Philippines. Dr Smith has emphasised the importance of strategic relationships formed at international toxicology meetings to navigate procurement processes effectively. Recent enhancements, optimised for iPads, tablets, and smartphones, ensure accessibility while maintaining the database's gold-standard, medically reviewed content. Features include phonetic searches, synonym recognition, and toxicovigilance monitoring for emerging risks. Free access is provided to developing countries via the WHO Hinari programme and Médecins Sans Frontières, underscoring a commitment to global health equity. Through her efforts, Dr Tracey Smith has significantly amplified the influence of University of Otago research on international clinical toxicology practices.